Accolade, Inc.
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, … Read more
Market Cap & Net Worth: Accolade, Inc. (ACCD)
Accolade, Inc. (NASDAQ:ACCD) has a market capitalization of $575.59 Million ($575.59 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10801 globally and #4943 in its home market, demonstrating a 0.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Accolade, Inc.'s stock price $7.02 by its total outstanding shares 81993104 (81.99 Million).
Accolade, Inc. Market Cap History: 2020 to 2025
Accolade, Inc.'s market capitalization history from 2020 to 2025. Data shows growth from $3.57 Billion to $575.59 Million (70.56% CAGR).
Index Memberships
Accolade, Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.02% | #297 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1101 of 3165 |
Weight: Accolade, Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Accolade, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Accolade, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.68x
Accolade, Inc.'s market cap is 0.68 times its annual revenue
1.54x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $3.57 Billion | $132.51 Million | -$51.37 Million | 26.92x | N/A |
| 2021 | $2.16 Billion | $170.36 Million | -$50.65 Million | 12.69x | N/A |
| 2022 | $638.73 Million | $310.02 Million | -$123.12 Million | 2.06x | N/A |
| 2023 | $984.74 Million | $363.14 Million | -$459.65 Million | 2.71x | N/A |
| 2024 | $280.42 Million | $414.29 Million | -$99.81 Million | 0.68x | N/A |
Competitor Companies of ACCD by Market Capitalization
Companies near Accolade, Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Accolade, Inc. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Accolade, Inc. Historical Marketcap From 2020 to 2025
Between 2020 and today, Accolade, Inc.'s market cap moved from $3.57 Billion to $ 575.59 Million, with a yearly change of 70.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $575.59 Million | +105.26% |
| 2024 | $280.42 Million | -71.52% |
| 2023 | $984.74 Million | +54.17% |
| 2022 | $638.73 Million | -70.45% |
| 2021 | $2.16 Billion | -39.40% |
| 2020 | $3.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Accolade, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $575.59 Million USD |
| MoneyControl | $575.59 Million USD |
| MarketWatch | $575.59 Million USD |
| marketcap.company | $575.59 Million USD |
| Reuters | $575.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.